Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
| ▸ | LIPE | Q05469 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5665614 | 0.93 | ELANE (0.44) | ELANELIPEHPGDCYP11B1CYP11B2 | |
| SCHEMBL8028437 | 0.91 | TAAR1 (0.50) | ELANEMEN1KMT2AMAPTCYP1A2 | |
| SCHEMBL6924446 | 0.89 | RAB9A (0.46) | ELANEMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL6565732 | 0.82 | HSD17B10 (0.47) | ELANEMEN1KMT2AMAPTCYP1A2 | |
| SCHEMBL56865 | 0.82 | KMT2A (0.50) | ELANELIPEHPGDCYP11B1CYP11B2 | |
| SCHEMBL6564201 | 0.82 | ELANE (0.52) | ELANEHPGDMEN1KMT2AMAPT | |
| SCHEMBL7063178 | 0.82 | ELANE (0.50) | ELANELIPEHPGDCYP11B1CYP11B2 | |
| SCHEMBL8465167 | 0.81 | LIPE (0.49) | ELANELIPEHPGDCYP11B1CYP11B2 | |
| SCHEMBL9578961 | 0.80 | MAPT (0.50) | ELANEHPGDMEN1KMT2AMAPT | |
| SCHEMBL1254449 | 0.80 | ELANE (0.48) | ELANELIPEHPGDCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 953 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116496445-B | Star polymer, preparation method and application thereof, dispersing agent and dispersing method | 中国科学院宁波材料技术与工程研究所 | 2025-05-30 | — | — | CN | claimed |
| CN-116496445-A | Star polymer, preparation method and application thereof, dispersing agent and dispersing method | 中国科学院宁波材料技术与工程研究所 | 2023-07-28 | — | — | CN | claimed |
| CN-116444742-A | Polymer based on phenol group modified aliphatic structure, preparation method thereof and dispersing agent | 中国科学院宁波材料技术与工程研究所 | 2023-07-18 | — | — | CN | claimed |
| CN-116332809-A | Process for producing alkylamine derivative and intermediate for production thereof | 味之素株式会社 | 2023-06-27 | — | — | CN | claimed |
| CN-115536556-A | Process for producing alkylamine derivative and intermediate for producing the same | 味之素株式会社 | 2022-12-30 | — | — | CN | claimed |
| CN-109689848-A | Spice composition | 奇华顿股份有限公司 | 2019-04-26 | — | — | CN | claimed |
| EP-3305760-A1 | METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2018-04-11 | — | — | EP | claimed |
| US-20180079715-A1 | METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2018-03-22 | — | — | US | claimed |
| US-20170298029-A1 | RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2017-10-19 | — | — | US | claimed |
| CN-107073153-A | The product of material is reduced comprising stench | 宝洁公司 | 2017-08-18 | — | — | CN | claimed |
| EP-2125754-A1 | AN IMPROVED PROCESS FOR PREPARATION OF ROSUVASTATIN CALCIUM | Aurobindo Pharma Limited (IN) | 2009-12-02 | — | — | EP | claimed |
| WO-2008096257-A1 | AN IMPROVED PROCESS FOR PREPARATION OF ROSUVASTATIN CALCIUM | AUROBINDO PHARMA LIMITED (IN) | 2008-08-14 | — | — | WO | claimed |
| US-20080153836-A1 | N-(2,4-Dioxo-1,4-dihydro-2H-quinazolin-3-yl)-methanesulfonamide derivatives; condensation, cyclization, reduction; AMPA (A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonists; schizophrenia, bipolar disorders, Parkinson's Disease, antiepileptic agents; psychological disorders | NOVARTIS AG (CH) | 2008-06-26 | — | — | US | claimed |
| EP-1871749-A1 | 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS | Novartis AG (US) | 2008-01-02 | — | — | EP | claimed |
| WO-2006108591-A1 | 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS | NOVARTIS AG (CH) | 2006-10-19 | — | — | WO | claimed |
| US-20060106083-A1 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PHARMACIA ITALIA S.P.A. (IT) | 2006-05-18 | — | — | US | claimed |
| JP-2005534635-A | — | — | 2005-11-17 | — | — | JP | claimed |
| EP-1506176-A1 | AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | Pharmacia Italia S.p.A. (IT) | 2005-02-16 | — | — | EP | claimed |
| WO-2003097610-A1 | AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA ITALIA S.P.A. (IT) | 2003-11-27 | — | — | WO | claimed |
| US-6015656-A | TABULAR SILICA DISPERSION OBTAINED BY MIXING TABULAR SILICA, GELATIN, CYCLODEXTRIN, COMPOUND CAPABLE OF CROSSLINKING GELATIN | KONICA CORPORATION (JP) | 2000-01-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106083-A1 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | MAP3K15, MAP3K3, MAP3K20 | ELANE 3929/4885LIPE 3391/4885HPGD 3158/4885 |
| US-20170298029-A1 | RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF | BRAF, RAF1, ARAF | ELANE 3035/4885LIPE 3001/4885HPGD 2930/4885 |
| US-20180079715-A1 | METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE | CASR, TAAR1, UTS2R | ELANE 3914/4885LIPE 2871/4885HPGD 2454/4885 |
| US-20080153836-A1 | N-(2,4-Dioxo-1,4-dihydro-2H-quinazolin-3-yl)-methanesulfonamide derivatives; condensation, cyclization, reduction; AMPA (A-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonists; schizophrenia, bipolar disorders, Parkinson's Disease, antiepileptic agents; psychological disorders | GRIN2A, GRIN1, GRIN2D | ELANE 4842/4885LIPE 4744/4885HPGD 1346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.